Oral News and Research

RSS

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19.

14 May 2020

Two new devices could offer additional safety for health care workers during COVID-19

Treating patients with COVID-19 means health care workers are putting their own health and safety on the line each day.

14 May 2020

Research reveals how long SARS-CoV-2 survives on surfaces, in feces and urine

A new study published on the preprint server medRxiv* in May 2020 shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease can remain viable for a maximum of one week on smooth environmental surfaces, for several hours in human feces, and for a maximum of 4 days in human urine. This knowledge could help guide disinfection policies to control the virus spread.

14 May 2020

Experts highlight triumph over polio and hope to do the same for COVID-19

For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.

14 May 2020

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.

13 May 2020

Nomograms can predict the risk of treatment delays for head and neck cancer patients

More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs inside the mouth and throat. For patients who undergo surgery to treat this cancer, guidelines recommend that prompt initiation of radiotherapy -- within six weeks -- is critical for best outcomes.

13 May 2020

Water fluoridation not linked to increased risk of osteosarcoma, study shows

The Journal of Dental Research published today the results of a study that demonstrated that community water fluoridation is not associated with increased risk of osteosarcoma.

12 May 2020

Simple saliva test detects early throat cancer

A simple saliva test developed by QUT biomedical scientists has detected early throat cancer in a person who had no symptom and no clinical signs of cancer.

12 May 2020

Clinical trial launched to evaluate experimental COVID-19 therapies

Clinical leaders from the University of Kentucky's Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19.

11 May 2020

Therapeutic peptides that can be taken orally

Peptides are short chains of amino acids that occur in our body, in plants or bacteria to control diverse functions.

11 May 2020

Innovative antibacterial solution enables professional-level dental hygiene at home

Elective dental procedures have been restricted globally due to the Covid-19 pandemic. Novel innovation enables professional-level oral hygiene at home.

11 May 2020

No evidence COVID-19 is spread by fecal-oral transmission

A new study published on the preprint server medRxiv* in May 2020 shows that in patients who test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pharyngeal and fecal samples, the virus persists longer in the fecal samples than in the pharyngeal samples. However, fecal-oral transmission does not appear to occur.

10 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020

Study sheds light on how a cellular pathway in plants senses danger signals

In nature, every species must be equipped with a strategy to be able to survive in response to danger. Plants, too, have innate systems that are triggered in response to a particular threat, such as insects feeding on them.

8 May 2020

New guidance released for treating patients with osteoporosis during COVID-19 crisis

The Endocrine Society joined a coalition of leading bone health organizations to release guidance for healthcare professionals treating patients with osteoporosis in the era of COVID-19.

8 May 2020

Predicting the dose for repurposing nitazoxanide in COVID-19

A new study published on the preprint server medRxiv in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in COVID-19 prevention and treatment. The researchers say, “It was possible to achieve plasma and lung tizoxanide concentrations, using proven safe doses of nitazoxanide, that exceed the EC90 for SARS-CoV-2.”

7 May 2020

Oral News and Research

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Two new devices could offer additional safety for health care workers during COVID-19

Research reveals how long SARS-CoV-2 survives on surfaces, in feces and urine

Experts highlight triumph over polio and hope to do the same for COVID-19

Trial E3311: Less intense treatment for HPV+ oropharynx cancer shows positive results

Nomograms can predict the risk of treatment delays for head and neck cancer patients

Water fluoridation not linked to increased risk of osteosarcoma, study shows

Simple saliva test detects early throat cancer

Clinical trial launched to evaluate experimental COVID-19 therapies

Therapeutic peptides that can be taken orally

Innovative antibacterial solution enables professional-level dental hygiene at home

No evidence COVID-19 is spread by fecal-oral transmission

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

Study sheds light on how a cellular pathway in plants senses danger signals

New guidance released for treating patients with osteoporosis during COVID-19 crisis

Predicting the dose for repurposing nitazoxanide in COVID-19

Vitamin D could improve outcomes in COVID-19

EFP develops safety protocol for dental practices during Covid-19

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News